Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB: FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce that Mr. Sheldon Inwentash, Dr. Eugene Dubossarsky and Mr. Antanas Guoga have joined its newly created Initial Coin Offering (ICO) Advisory Board for the pending launch of its Citizen Green Token.
Mr. Inwentash is chairman and chief executive officer of ThreeD Capital Inc., a Toronto-based venture capital firm specializing in investments in blockchain, cryptocurrencies, A.I. and junior resources. He has a track record of investing in early stage companies that grow to become large successful acquisition targets and has recently refocused his investment strategy to include new and emerging sectors of blockchain and cryptocurrencies.
Dr. Dubossarsky holds a Ph.D.in Machine Learning (Neural Networks) and is the Chief Data Scientist at AlphaZetta, a global analytics consultancy. As a consultant, he advises businesses with data science strategy including advanced methods to improve data science performance and deliver more measurable value. He specializes in applying data science to an entrepreneurial setting, financial trading and online start-ups, and has worked with numerous cryptocurrency companies.
Mr. Antanas Guoga, or better known as “Tony G”, is a poker player, entrepreneur, politician and an expert in cryptocurrencies and blockchain. He is currently Lithuania’s member of the European Parliament and a ICO special advisor to Bankera, which is one of the largest ICOs on record with a raise of over EUR46 million. His involvement in other blockchain and cryptocurrency success includes SpectroCoin, a cryptocurrency exchange that provides payment processing and other financial services, and the recently-announced online cryptocurrency poker room CoinPoker.
“I am extremely delighted to have such incredible individuals joining the ICO Advisory Board, helping to provide the strength to guarantee to the success of our ICO,” said Brad Moore, CEO of GCAC. “Rarely has there been such a talented and skilled group, all with multiple levels of engagement with GCAC. Our ICO and the Citizen Green Coin is promising to become an industry game changer, not only in blockchain and cryptocurrency, but also in helping people around the world people use medical cannabis in a safe and smart way. I look forward to working alongside Sheldon, Eugene and Tony G to shape the future of GCAC and create value for our shareholders.”
GCAC is finalizing the launch of its own initial coin offering, Citizen Green Tokens, as the basis of a medical cannabis loyalty program. The Citizen Green Token is part of Citizen Green data platform, the world’s first end to-end data aggregation and user delivery system for the medical cannabis industry. Digital tokens and blockchain will play an important role on providing a value based, trusted environment where users can share information and earn tokens for their participation.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in medical cannabis. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Chief Executive Officer
For more information, please contact:
Corporate Communications Canada & Europe
Corporate Communications United States
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Click here to connect with Global Cannabis Applications Corp. (CSE:APP, FSE:2FA, OTCQB: FUAPF) for an Investor Presentation.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).